Patent ID: 11957876
Assignee: BETA BIONICS, INC.
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A

Claim 0:
1. An automated glucose level control system configured to generate a backup therapy protocol comprising insulin therapy dosing recommendations derived from autonomously determined doses of insulin, the automated glucose level control system comprising:
a medicament delivery interface configured to operatively connect to a medicament pump for infusing medicament into a subject;
a memory configured to store specific computer-executable instructions; and
a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:
track insulin therapy administered to the subject over a tracking period by the automated glucose level control system, wherein tracking the insulin therapy comprises storing an indication of autonomously determined doses of insulin delivered to the subject as correction boluses of insulin or as basal doses of insulin;
generate the backup therapy protocol comprising at least one of a plurality of backup therapy dosing recommendations, wherein the plurality of backup therapy dosing recommendations comprises:
a correction dosing recommendation comprising a correction factor based on at least some of the correction boluses of insulin administered during the tracking period; and
a basal dosing recommendation comprising a basal rate based on at least some of the basal doses of insulin administered during the tracking period; and

output the backup therapy protocol as determined by the automated glucose level control system for the purpose of being used when the automated glucose level control system is not providing therapy to the subject.